Daiwa Securities Group
XBI icon

Daiwa Securities Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Daiwa Securities Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,000
Closed -$186K – 924
2014
Q4 		$186K Buy
+3,000
New +$171K ﹤0.01% 655

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Daiwa Securities Group's XBI Position: Q1 2015 in Review

Daiwa Securities Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2015, closing a stake of 3,000 shares — an estimated $186K sold.

Daiwa Securities Group first reported a position in XBI in Q4 2014 and held it in 1 quarter. The position peaked at $186K in Q4 2014. 180 funds tracked by Wall St. Rank hold XBI as of Q1 2015.

  • Daiwa Securities Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2015 after selling out during the quarter.
  • Daiwa Securities Group sold 3,000 State Street SPDR S&P Biotech ETF shares in Q1 2015, an estimated $186K.
  • Daiwa Securities Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 1 quarter.
  • Daiwa Securities Group's State Street SPDR S&P Biotech ETF position peaked at $186K in Q4 2014.
  • 180 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2015.

Based on Daiwa Securities Group's 13F filing for Q1 2015, filed 12 May 2015.